AS Latvijas Juras medicinas centrs Second Quarter 2024 Earnings: €0.15 loss per share (vs €0.082 loss in 2Q 2023)
The AS Latvijas Juras medicinas centrs' share price has remained steady over the past week. Despite this, two warning signs have been identified for the company, emphasizing the importance of considering investment risks. Contact us for feedback or concerns.